Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Pharmaceutical industry news


From To
Trade agreements should not hinder efforts towards universal access to HIV prevention, treatment, care and support

The Joint United Nations Programme on HIV/AIDS (UNAIDS) calls on all countries to ensure efforts towards universal access to HIV prevention, treatment, care and support are not impeded by bilateral and multilateral trade agreements.

09 December 2010
Abbott receives FDA approval for first automated molecular test for assessing hepatitis B treatment

Abbott announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.

01 September 2010
GSK and Pfizer HIV divisions to form new company

GlaxoSmithKline (GSK) and Pfizer have merged the HIV sections of their business to form a new company. In a statement issued on April 16th, they

17 April 2009
Michael Carter
WHO issues guidance for doctors, governments, patients on what to do about delisted ARVs

WHO advice after delisting of a number of generic antiretroviral products.

03 September 2004
HIV & AIDS treatment in practice
GSK cuts price of HIV drugs to poorest countries

Pharmaceutical giant, GlaxoSmithKline (GSK), has announced that it is halving the price of some of the drugs in its anti-HIV portfolio for 63 nations, including

28 April 2003
Michael Carter
GSK acquire rights to develop new CCR5 antagonist

Today in London, GlaxoSmithKline (GSK) announced it has acquired exclusive worldwide rights to ONO-4128, a new cellular chemokine receptor (CCR5) antagonist discovered by Japan’s Ono

17 January 2003
Robert Fieldhouse

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.